Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

Trial Profile

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Alendronic acid (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Acronyms BILANZ
  • Most Recent Events

    • 23 May 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2011-000290-31).
    • 23 May 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 21 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top